Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Atara Biotherap Cmn (ATRA)

14.50 -0.25 (-1.69%)

6/23/2017  4:00pm

Open:

14.65

Pre. Close:

14.75

High:

14.75

Low:

13.85

Volume:

791,214

Market Cap:

422.08M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

15.08 - 15.37

15.37 - 15.56

Low:

12.9 - 13.27

13.27 - 13.51

Close:

13.74 - 14.53

14.53 - 15.06

Technical analysis  (as of: 2017-06-23 4:32:16 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 18.51     One year: 21.62

Support:

Support1: 13.35    Support2: 11.80

Resistance:

Resistance1: 15.85    Resistance2: 18.51

Pivot:

13.48

Moving Averages:

MA(5): 14.11     MA(20): 13.59

MA(100): 16.32     MA(250): 17.86

MACD:

MACD(12,26): -0.32     Signal(12,26,9): -0.61

%K %D:

%K(14,3): 80.41     %D(3): 74.01

RSI:

RSI(14): 53.23

52-Week:

High: 25.73  Low: 11.80  Change(%): -34.3

Average Vol(K):

3-Month: 296  10-Days 364

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
ATRA has closed below upper band by 13.1%. Bollinger Bands are 32.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 10 May 2017 12:00:00 GMT
Atara Biotherapeutics Enhances Commercial Expertise with the Appointment of Dr ...

Wed, 24 May 2017 12:00:00 GMT
Atara Biotherapeutics to Present at Three Upcoming Investor Conferences

Wed, 08 Feb 2017 23:03:45 GMT
Atara Biotherapeutics Coming to Thousand Oaks

Thu, 20 Apr 2017 21:16:25 GMT
Atara Biotherapeutics shares rise on MS drug study results

Mon, 03 Apr 2017 12:03:22 GMT
Atara Bio Expands Management Team, Appoints Joe Newell as Executive Vice ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

29.11

Shares Float (M)

10.54

% Held by Insiders

10.05

% Held by Institutions

49.00

Shares Short (K)

5030

Shares Short Prior Month (K)

3840

Stock Financials

EPS

-3.050

EPS Est. Current Year

-3.630

EPS Est. Next Year

-3.690

EPS Est. Next Quarter

-0.880

Forward EPS

-3.695

Book Value (p.s.)

8.010

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-20.4

Return on Equity (ttm)

-32.8

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-3.084

Qtrly Earnings Growth

Operating Cash Flow (M)

-69.57

Levered Free Cash Flow (M)

-42.21

FoxReading.com

Valuation

P/E

-4.75

P/E Growth Ratio

-0.02

P/BV

1.81

P/S

P/CF

-6.07

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.